(Q43446793)

23 November 2017

p53 overexpression in advanced-stage endometrial adenocarcinoma (English)

1 reference

23 November 2017

1 reference

1 reference

7

Berchuck A

1 reference

23 November 2017

Kohler MF

1

1 reference

23 November 2017

Carney P

2

1 reference

23 November 2017

Dodge R

3

1 reference

23 November 2017

Soper JT

4

1 reference

23 November 2017

Clarke-Pearson DL

5

1 reference

23 November 2017

Marks JR

6

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

American Journal of Obstetrics and Gynecology

23 November 2017

1 reference

23 November 2017

175

1 reference

23 November 2017

5

1 reference

23 November 2017

1246-1252

1 reference

Molecular basis of endometrial cancer

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Clinicopathological characteristics of p53 overexpression in endometrial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

A collaborative study of differences in the survival rates of black patients and white patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Racial differences in survival of women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Racial differences in tumor grade among women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Contrasts in survival of black and white cancer patients, 1960-73

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2896%2970036-4

10.1016/S0002-9378(96)70036-4

7 January 2021

Identifiers

DOI

1 reference

release_ywb6c5kdqrgqznpyzl5fwqb2pa

23 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ywb6c5kdqrgqznpyzl5fwqb2pa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference